Abstract: A device may include a flexible tube comprising: a distal end, a proximal tip, the proximal tip comprising a suction line extension being configured for placement in a uterine cavity of a uterus after childbirth, a tube center of the flexible tube; and at least one lumen around the tube center, the at least one lumen comprising a suction line, the suction line being in communication with a source of negative pressure and the suction line extension, the suction line extension being configured for applying the negative pressure to the uterine cavity using the source of the negative pressure thereby causing mechanical hemostasis of bleeding blood vessels of a uterine wall of the uterine cavity. Embodiments include an anchoring mechanism being proximate to the suction line extension along the flexible tube, the anchoring mechanism being configured for maintaining the suction line extension in a desired position within the uterine cavity.

Abstract: A device may include a flexible tube comprising: a distal end, a proximal tip, the proximal tip comprising a suction line extension being configured for placement in a uterine cavity of a uterus after childbirth, a tube center of the flexible tube; and at least one lumen around the tube center, the at least one lumen comprising a suction line, the suction line being in communication with a source of negative pressure and the suction line extension, the suction line extension being configured for applying the negative pressure to the uterine cavity using the source of the negative pressure thereby causing mechanical hemostasis of bleeding blood vessels of a uterine wall of the uterine cavity. Embodiments include an anchoring mechanism being proximate to the suction line extension along the flexible tube, the anchoring mechanism being configured for maintaining the suction line extension in a desired position within the uterine cavity.

Abstract: A device may include a flexible tube comprising: a distal end, a proximal tip, the proximal tip comprising a suction line extension being configured for placement in a uterine cavity of a uterus after childbirth, a tube center of the flexible tube; and at least one lumen around the tube center, the at least one lumen comprising a suction line, the suction line being in communication with a source of negative pressure and the suction line extension, the suction line extension being configured for applying the negative pressure to the uterine cavity using the source of the negative pressure thereby causing mechanical hemostasis of bleeding blood vessels of a uterine wall of the uterine cavity. Embodiments include an anchoring mechanism being proximate to the suction line extension along the flexible tube, the anchoring mechanism being configured for maintaining the suction line extension in a desired position within the uterine cavity.

Abstract: The present disclosure describes, in part, an enzyme-mediated radical initiating system and methods of using the system to produce polymers, including polymeric hydrogels, at ambient conditions.

Abstract: In a first embodiment, a lighting fixture is configured as a power over Ethernet (PoE) powered device (PD), which is capable of facilitating Ethernet-based communications with and receiving power from a PoE device, such as a PoE switch, over a single cable. In a second embodiment, a lighting fixture is configured as a PoE power source equipment (PSE) device, which is capable of facilitating Ethernet-based communications with and supplying power to one or more control elements.

Abstract: Hydrogels releasing or producing NO, most preferably polymerizable biodegradable hydrogels capable of releasing physiological amounts of NO for prolonged periods of time, are applied to sites on or in a patient in need of treatment thereof for disorders such as restenosis, thrombosis, asthma, wound healing, arthritis, penile erectile dysfunction or other conditions where NO plays a significant role. The polymeric materials can be formed into films, coatings, or microparticles for application to medical devices, such as stents, vascular grafts and catheters. The polymeric materials can also be applied directly to biological tissues and can be polymerized in situ. The hydrogels are formed of macromers, which preferably include biodegradable regions, and have bound thereto groups that are released in situ to elevate or otherwise modulate NO levels at the site where treatment is needed.

Abstract: Peptide-modified polyurethanes comprising the reaction product of an isocyanate, a chain extender, and a peptide are provided. Also provided processes for making a peptide-modified polyurethane comprising: providing an isocyanate; providing a chain extender; providing a peptide; and allowing the isocyanate, chain extender, and peptide to react thereby forming the peptide-modified polyurethane, as well as methods for treating a subject comprising: providing a peptide-modified polyurethane that comprises the reaction product of an isocyanate, a chain extender, and a peptide; and administering the peptide-modified polyurethane to the subject.

Abstract: Dendritic nitric oxide donors having the formula: [P]-[(A)y]x-[(NO)z]q wherein P is a core that comprises a biocompatible polymer; A is a branching unit monomer that comprises at least one end group capable of reversibly attaching NO; (NO) is nitric oxide; x, y, and z are positive integers greater than or equal to 1; and q is a positive integer greater than or equal to y, as well as medical devices and kits that comprise dendritic nitirc oxide donors, are provided. Also provided are methods of delivering nitric oxide into a recipient subject comprising: providing a dendritic nitric oxide donor; and administering the dendritic nitric oxide donor into the recipient subject, such that the dendritic nitric oxide donor releases NO in the recipient subject.

Abstract: The present invention provides tissue engineering scaffolds capable of inducing extracellular matrix production by a cell attached to the tissue engineering scaffolds, the tissue engineering scaffolds comprising: a scaffold; a polymer tether covalently coupled to the scaffold; and a TGF-? molecule that is covalently coupled to the polymer tether, wherein the TGF-? molecule is present at a concentration sufficient to elicit production of extracellular matrix by the cell attached to the tissue engineering scaffold without increasing cellular proliferation of the attached cell.

Abstract: The present invention provides methods for repair or replacement of tissue comprising applying or implanting, at a site in need of repair, a tissue engineering scaffold. The present invention also provides tissue engineering scaffolds capable of inducing extracellular matrix production by a cell attached to the tissue engineering scaffold comprising: a scaffold; a polymer tether covalently coupled to the scaffold; and a matrix-enhancing molecule that is covalently coupled to the polymer tether, wherein the matrix-enhancing molecule is present at a concentration sufficient to elicit production of extracellular matrix by the cell attached to the tissue engineering scaffold without increasing cellular proliferation of the attached cell, wherein the matrix-enhancing molecule is selected from the group consisting of ascorbic acid, angiotensin II, insulin-like growth factor, and combinations thereof.

Abstract: The present invention provides nanoshell particles (“nanoshells”) for use in biosensing applications, along with their manner of making and methods of using the nanoshells for in vitro and in vivo detection of chemical and biological analytes, preferably by surface enhanced Raman light scattering. The preferred particles have a non-conducting core and a metal shell surrounding the core. For given core and shell materials, the ratio of the thickness (i.e., radius) of the core to the thickness of the metal shell is determinative of the wavelength of maximum absorbance of the particle. By controlling the relative core and shell thicknesses, biosensing metal nanoshells are fabricated which absorb light at any desired wavelength across the ultraviolet to infrared range of the electromagnetic spectrum. The surface of the particles are capable of inducing an enhanced SERS signal that is characteristic of an analyte of interest.

Abstract: The present invention provides a photoactuator comprising a plurality of nanoparticles and a thermally sensitive material. The photoactuator is useful for a variety of applications including macroscale and nanoscale applications. The nanoparticles are in thermal contact with the thermally sensitive material. The nanoparticles are engineered to achieve peak resonance at a given wavelength of light such that upon illumination. Upon illumination of the thermally sensitive material, the nanoparticles convert the light to heat, which is transferred to the thermally sensitive material, inducing a change in volume in the thermally sensitive material. The present invention is useful for actuating devices, especially in microfluidic devices. Methods for making a photoactuator and various embodiments thereof are also provided.